-6%-6%
Availability: Άμεσα Διαθέσιμο

COVID-19 From Bench to Bedside 1st Edition

Debmalya Barh, Kenneth Lundstrom
ISBN: 9781032040622
ISBN: 9781032040622
Εκδόσεις:
Διαστάσεις 25 × 18 cm
Μορφή

Εκδόσεις

Ημ. Έκδοσης

Σελίδες

Έκδοση

Συγγραφείς

Κύριος Συγγραφέας

Original price was: 89,00€.Η τρέχουσα τιμή είναι: 84,00€.(Περιλαμβάνεται ΦΠΑ 6%)

Διαθέσιμο - Προπαραγγελία|Διαθεσιμότητα: 23-28 ημέρες

Κατηγορίες: ,

Περιγραφή

The COVID-19 pandemic has affected the entire world in an unprecedented way, and this book provides an overview of the historical facts as well as ongoing approaches to tackle the COVID-19 pandemic. Experts of the respective domains provide details on anti-SARS-CoV-2 drug strategies, including repurposing drugs used for other indications and the development of novel drugs looking at different approaches to target virus entry and replication. COVID-19 vaccine development based on inactivated and attenuated live virus, protein subunit and peptide-based vaccines and utilization of vaccine candidates based on viral vectors, DNA and RNA are presented for both preclinical studies and clinical trials.

Key Features

  • Explains the background of the COVID-19 pandemic, the current progress in the development of treatments and prevention of COVID-19 including future aspects of dealing with the pandemic
  • Serves as a timely repository of knowledge on COVID-19 for researchers and medical professionals engaged in its management

Περιεχόμενα

Chapter 1 Coronavirus epidemics and the current COVID-19 pandemic
Aparna Bhardwaj, Prateek Kumar, Shivani Krishna Kapuganti, Vladimir N. Uversky, and Rajanish Giri

Chapter 2 Biology of Coronaviruses and Predicted Origin of SARS-CoV-2
Giorgio Palù, Alberto Reale, Nicolas G. Bazan, Pritam Kumar Panda, Vladimir N. Uversky, Murat Seyran, Alaa A. A. Aljabali, Samendra P. Sherchan, Gajendra Kumar Azad, Wagner Baetas-da-Cruz, Parise Adadi, Murtaza M. Tambuwala, Bruce D. Uhal, Kazuo Takayama, Ángel Serrano-Aroca, Tarek Mohamed Abd El-Aziz1, Adam M. Brufsky and Kenneth Lundstrom

Chapter 3 Therapeutic Challenges in COVID-19
Alaa A. A. Aljabal1, Murtaza M. Tambuwala, Debmalya Barh and Kenneth Lundstrom

Chapter 4 Prevention and Control Strategies for COVID-19 Pandemic
Isfendiyar Darbaz, Gizem Morris, and Şükrü Tüzmen

Chapter 5 Global Focus and Interdisciplinary Approaches in COVID-19 Research and Their Outcomes
Hülya Şenol and Şükrü Tüzmen

Chapter 6 The evolution of COVID-19 diagnostics
Praveen Rai, Ballamoole Krishna Kumar, Deekshit Vijaya Kumar, Prashant Kumar, Anoop Kumar, Shashi Kumar Shetty and Biswajit Maitia

Chapter 7 Drug repurposing and novel antiviral drugs for COVID-19 management
Shailendra Dwivedi, Aakanksha Rawat, Amit Ranjan, Ruchika Agrawal, Radhieka Misra, Sunil Kumar Gupta, Surekha Kishore and Sanjeev Misra

Chapter 8 Convalescent Plasma and Antibody Therapy in COVID-19
Didem Rıfkı, Eymen Ü. Kılıç and, Şükrü Tüzmen

Chapter 9 Application Stem Cell and Exosome Based Therapy in COVID-19
Suleyman Gokhan Kara and Ayla Eker Sariboyaci

Chapter 10 Host and Pathogen-Specific Drug Targets in COVID-19
Bruce D. Uhal, David Connolly, Farzaneh Darbeheshti, Yong-Hui Zheng, Ifeanyichukwu E. Eke. Yutein Chung and Lobelia Samavati

Chapter 11 Computational biology and bioinformatics in anti-SARS-CoV-2 drug development
Vladimir N. Uversky

Chapter 12 Nanomaterials in COVID-19 drug development
Alaa A A Aljabali, Ángel Serrano-Aroca and Murtaza M. Tambuwala

Chapter 13 Vaccine Development Strategies and the Current Status of COVID-19 Vaccines
Mohsen Akbarian, Kenneth Lundstrom, Elrashdy M. Redwan and Vladimir N. Uversky

Chapter 14 Clinical trials of COVID-19 therapeutics and vaccines: history, current status, and limitations
Candan Hizel Perry, Havva Ö. Kılgöz and Şükrü Tüzmen

Chapter 15 Lessons Learned from COVID-19 and Their Implementations for Future Pandemics
Mauricio Corredor, Debmalya Barh and Kenneth Lundstrom

Σχετικά προϊόντα